Search research articles
Contact Us
Filters
Showing results (511-520 of 543) with videos related to
Page
of 55
Sort By:
Biology
|
June 24, 2022
Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro
Jessica D Hess, Luca H Macias, Denisse A Gutierrez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel
C Sessa, D Tosi, L Viganò, et al.
Scientific Reports
|
March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo
Nicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
The Journal of Investigative Dermatology
|
August 24, 2007
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome
Jessica S Yoon, Sarah M Newton, Maria Wysocka, et al.
The Journal of Biological Chemistry
|
June 27, 2013
CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak
Kimberly N Kremer, Kevin L Peterson, Paula A Schneider, et al.
Investigational New Drugs
|
March 21, 2017
Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
A Stathis, D Hess, R von Moos, et al.
Blood
|
June 3, 2004
Association of Foxp3 regulatory gene expression with graft-versus-host disease
Yuji Miura, Christopher J Thoburn, Emilie C Bright, et al.
Surgical Endoscopy
|
July 1, 2017
Vacuum-assisted early transanal closure of leaking low colorectal anastomoses: the CLEAN study
W A A Borstlap, G D Musters, L P S Stassen, et al.
ESMO Open
|
October 30, 2025
A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)
K-L Koster, I Colombo, S Hayoz, et al.
Journal of Medicinal Chemistry
|
July 21, 1998
Novel and specific respiratory syncytial virus inhibitors that target virus fusion
W D Ding, B Mitsner, G Krishnamurthy, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 543) with videos related to
Sort By:
Page
of 55
Biology
|
June 24, 2022
Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro
Jessica D Hess, Luca H Macias, Denisse A Gutierrez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel
C Sessa, D Tosi, L Viganò, et al.
Scientific Reports
|
March 7, 2019
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo
Nicole D Vincelette, Husheng Ding, Amelia M Huehls, et al.
The Journal of Investigative Dermatology
|
August 24, 2007
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome
Jessica S Yoon, Sarah M Newton, Maria Wysocka, et al.
The Journal of Biological Chemistry
|
June 27, 2013
CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak
Kimberly N Kremer, Kevin L Peterson, Paula A Schneider, et al.
Investigational New Drugs
|
March 21, 2017
Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
A Stathis, D Hess, R von Moos, et al.
Blood
|
June 3, 2004
Association of Foxp3 regulatory gene expression with graft-versus-host disease
Yuji Miura, Christopher J Thoburn, Emilie C Bright, et al.
Surgical Endoscopy
|
July 1, 2017
Vacuum-assisted early transanal closure of leaking low colorectal anastomoses: the CLEAN study
W A A Borstlap, G D Musters, L P S Stassen, et al.
ESMO Open
|
October 30, 2025
A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK)
K-L Koster, I Colombo, S Hayoz, et al.
Journal of Medicinal Chemistry
|
July 21, 1998
Novel and specific respiratory syncytial virus inhibitors that target virus fusion
W D Ding, B Mitsner, G Krishnamurthy, et al.
Page
of 55